Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Advances in multi-omics study of biomarkers of glycolipid metabolism disorder. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1038/nrendo.2017.151
10.1038/nrendo.2017.151 · External reference
The Relationship Between Obesity, Overweight, and the Human Development Index in World Health Organization Eastern Mediterranean Region Countries
10.3961/jpmph.19.100 · 2020 · External reference
Repositioning of the global epicentre of non-optimal cholesterol
10.1038/s41586-020-2338-1 · 2020 · External reference
10.1016/j.amjmed.2013.02.035
10.1016/j.amjmed.2013.02.035 · External reference
The Intervention Effect of Traditional Chinese Medicine on the Intestinal Flora and Its Metabolites in Glycolipid Metabolic Disorders
2019 · External reference
The combination of cinnamaldehyde and kaempferol ameliorates glucose and lipid metabolism disorders by enhancing lipid metabolism via AMPK activation
10.1016/j.jff.2021.104556 · 2021 · External reference
Synergistic Effect of Omega-3 Fatty Acids and Oral-Hypoglycemic Drug on Lipid Normalization through Modulation of Hepatic Gene Expression in High Fat Diet with Low Streptozotocin-Induced Diabetic Rats
10.3390/nu12123652 · 2020 · External reference
Synergistic activation of thermogenic adipocytes by a combination of PPARγ activation, SMAD3 inhibition and adrenergic receptor activation ameliorates metabolic abnormalities in rodents
10.1007/s00125-019-4938-6 · 2019 · External reference
The effects of hypoxia on hunger perceptions, appetite-related hormone concentrations and energy intake: A systematic review and meta-analysis
10.1016/j.appet.2018.01.015 · 2018 · External reference
Corrigendum to “Deficiency of leptin receptor in myeloid cells disrupts hypothalamic metabolic circuits and causes body weight increase” [Molecular Metabolism 7 (2018) 155–160]
10.1016/j.molmet.2018.12.006 · 2019 · External reference
10.2337/db11-0785
10.2337/db11-0785 · External reference
10.1016/j.cmet.2013.12.015
10.1016/j.cmet.2013.12.015 · External reference
10.1016/j.cmet.2015.04.008
10.1016/j.cmet.2015.04.008 · External reference
10.1016/j.metabol.2021.154892
10.1016/j.metabol.2021.154892 · External reference
10.1038/s41580-021-00390-6
10.1038/s41580-021-00390-6 · External reference
10.1038/s41586-019-1797-8
10.1038/s41586-019-1797-8 · External reference
10.1016/j.redox.2021.101887
10.1016/j.redox.2021.101887 · External reference
10.1038/nrendo.2015.189
10.1038/nrendo.2015.189 · External reference
10.1016/j.celrep.2021.109161
10.1016/j.celrep.2021.109161 · External reference
10.1007/s13238-020-00814-7
10.1007/s13238-020-00814-7 · External reference
10.3390/microorganisms8040527
10.3390/microorganisms8040527 · External reference
10.1016/j.arr.2021.101346
10.1016/j.arr.2021.101346 · External reference
10.1038/s41576-020-0216-1
10.1038/s41576-020-0216-1 · External reference
10.1038/nature19806
10.1038/nature19806 · External reference
Unresolved reference
External reference
Correction: Transcription factor-7-like 2 (TCF7L2) gene acts downstream of the Lkb1/Stk11 kinase to control mTOR signaling, β cell growth, and insulin secretion
10.1074/jbc.aac118.006541 · 2018 · External reference
10.1038/ng1732
10.1038/ng1732 · External reference
Meta-analysis of association between TCF7L2 polymorphism rs7903146 and type 2 diabetes mellitus
10.1186/s12881-018-0553-5 · 2018 · External reference
10.1016/j.numecd.2017.10.012
10.1016/j.numecd.2017.10.012 · External reference
A common rs7903146 variant of the transcription factor 7-like 2 gene is associated with type 2 diabetes mellitus and fasting glucose in a Taiwanese population
10.1016/j.diabet.2016.05.003 · 2017 · External reference
Impact of KCNQ1, CDKN2A/2B, CDKAL1, HHEX, MTNR1B, SLC30A8, TCF7L2, and UBE2E2 on risk of developing type 2 diabetes in Thai population
10.1186/s12881-018-0614-9 · 2018 · External reference
Human peroxisome proliferator-activated receptor-gamma2: genetic mapping, identification of a variant in the coding sequence, and exclusion as the gene responsible for lipoatrophic diabetes
10.2337/diabetes.47.3.490 · 1998 · External reference
10.3390/ijms19072124
10.3390/ijms19072124 · External reference
10.1038/nature05616
10.1038/nature05616 · External reference
10.1126/science.1142382
10.1126/science.1142382 · External reference
10.2337/db08-0047
10.2337/db08-0047 · External reference
10.2337/db08-0877
10.2337/db08-0877 · External reference
10.1126/science.1151710
10.1126/science.1151710 · External reference
Influence of FTO rs9939609 polymorphism on appetite, ghrelin, leptin, IL6, TNFα levels, and food intake of women with morbid obesity
10.2147/dmso.s154978 · 2018 · External reference
10.1371/journal.pone.0165523
10.1371/journal.pone.0165523 · External reference
Common Variations in Perilipin rs1052700 and FTO rs3751812 Gene Variants, and Risk for Obesity and Type-2 Diabetes
2017 · External reference
10.1016/s0014-5793(97)00488-2
10.1016/s0014-5793(97)00488-2 · External reference
10.1126/science.270.5239.1166
10.1126/science.270.5239.1166 · External reference
10.1007/s00125-013-3031-9
10.1007/s00125-013-3031-9 · External reference
Sequence variants in the sulfonylurea receptor (SUR) gene are associated with NIDDM in Caucasians
10.2337/diab.45.6.825 · 1996 · External reference
10.1038/s41467-018-04951-w
10.1038/s41467-018-04951-w · External reference
10.1038/nature18642
10.1038/nature18642 · External reference
Identification of type 2 diabetes loci in 433,540 East Asian individuals
10.1038/s41586-020-2263-3 · 2020 · External reference
10.1038/nature14177
10.1038/nature14177 · External reference
10.1210/er.2013-1084
10.1210/er.2013-1084 · External reference
10.1016/j.cmet.2019.03.009
10.1016/j.cmet.2019.03.009 · External reference
10.2337/dci19-0066
10.2337/dci19-0066 · External reference
SLC47A1 gene rs2289669 G>A variants enhance the glucose-lowering effect of metformin via delaying its excretion in Chinese type 2 diabetes patients
10.1016/j.diabres.2015.05.003 · 2015 · External reference
Polymorphism of organic cation transporter 2 improves glucose-lowering effect of metformin via influencing its pharmacokinetics in Chinese type 2 diabetic patients
10.1007/s40291-014-0126-z · 2015 · External reference
10.1016/j.diabres.2006.10.021
10.1016/j.diabres.2006.10.021 · External reference
Ser1369Ala variant in sulfonylurea receptor gene ABCC8 is associated with antidiabetic efficacy of gliclazide in Chinese type 2 diabetic patients
10.2337/dc07-2248 · 2008 · External reference
KCNJ11 gene E23K variant and therapeutic response to sulfonylureas
10.1016/j.ejim.2011.10.018 · 2012 · External reference
Polymorphisms of GLP-1 receptor gene and response to GLP-1 analogue in patients with poorly controlled type 2 diabetes
2015 · External reference
Allelic variant in the glucagon-like peptide 1 receptor gene associated with greater effect of liraglutide and exenatide on gastric emptying: A pilot pharmacogenetics study
10.1111/nmo.13313 · 2018 · External reference
10.1210/en.2011-0286
10.1210/en.2011-0286 · External reference
A genetic variant in GLP1R is associated with response to DPP-4 inhibitors in patients with type 2 diabetes
10.1097/md.0000000000005155 · 2016 · External reference
DPP4 gene variation affects GLP-1 secretion, insulin secretion, and glucose tolerance in humans with high body adiposity
10.1371/journal.pone.0181880 · 2017 · External reference
Population Pharmacokinetic Modeling of Canagliflozin in Healthy Volunteers and Patients with Type 2 Diabetes Mellitus
10.1007/s40262-015-0307-x · 2016 · External reference
Influence of common polymorphisms in the SLC5A2 gene on metabolic traits in subjects at increased risk of diabetes and on response to empagliflozin treatment in patients with diabetes
10.1097/fpc.0000000000000268 · 2017 · External reference
Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study
10.1007/s00125-018-4675-2 · 2018 · External reference
CYP3A4 genotypes and plasma lipoprotein levels before and after treatment with atorvastatin in primary hypercholesterolemia
10.1016/j.amjcard.2003.08.078 · 2004 · External reference
Pharmacogenetic study of statin therapy and cholesterol reduction
10.1001/jama.291.23.2821 · 2004 · External reference
Apo A-I promoter polymorphism influences basal HDL-cholesterol and its response to pravastatin therapy
10.1016/s0021-9150(03)00094-7 · 2003 · External reference
10.1016/s0021-9150(01)00410-5
10.1016/s0021-9150(01)00410-5 · External reference
10.1038/nsmb.2921
10.1038/nsmb.2921 · External reference
Linking a role of lncRNAs (long non-coding RNAs) with insulin resistance, accelerated senescence, and inflammation in patients with type 2 diabetes
10.1186/s40246-018-0173-3 · 2018 · External reference
10.1016/j.cmet.2012.08.010
10.1016/j.cmet.2012.08.010 · External reference
Downregulation of lncRNA TUG1 affects apoptosis and insulin secretion in mouse pancreatic β cells
10.1159/000373999 · 2015 · External reference
10.1016/j.ijcard.2016.11.182
10.1016/j.ijcard.2016.11.182 · External reference
Downregulation of Long Noncoding RNA Gas5 Affects Cell Cycle and Insulin Secretion in Mouse Pancreatic β Cells
10.1159/000484191 · 2017 · External reference
10.1016/j.cmet.2015.04.003
10.1016/j.cmet.2015.04.003 · External reference
10.2337/db17-0799
10.2337/db17-0799 · External reference
10.1073/pnas.0804549105
10.1073/pnas.0804549105 · External reference
MicroRNA Networks in Pancreatic Islet Cells: Normal Function and Type 2 Diabetes
10.2337/dbi19-0016 · 2020 · External reference
10.1038/nature03076
10.1038/nature03076 · External reference
miR-375 gene dosage in pancreatic β-cells: implications for regulation of β-cell mass and biomarker development
10.1007/s00109-015-1296-9 · 2015 · External reference
10.1038/nm.3862
10.1038/nm.3862 · External reference
Novel lncRNA Erbb4-IR Promotes Diabetic Kidney Injury in db/db Mice by Targeting miR-29b
10.2337/db17-0816 · 2018 · External reference
10.1038/s41574-019-0260-0
10.1038/s41574-019-0260-0 · External reference
MicroRNAs of the miR-17∼9 family maintain adipose tissue macrophage homeostasis by sustaining IL-10 expression
10.7554/elife.55676 · 2020 · External reference
Obesity-induced overexpression of miR-802 impairs insulin transcription and secretion
10.1038/s41467-020-15529-w · 2020 · External reference
10.3390/cells9030659
10.3390/cells9030659 · External reference
10.1038/nature11928
10.1038/nature11928 · External reference
The circular RNA Cdr1as, via miR-7 and its targets, regulates insulin transcription and secretion in islet cells
10.1038/srep12453 · 2015 · External reference
Hsa_circ_0054633 in peripheral blood can be used as a diagnostic biomarker of pre-diabetes and type 2 diabetes mellitus
10.1007/s00592-016-0943-0 · 2017 · External reference
Human circular RNA–0054633 regulates high glucose–induced vascular endothelial cell dysfunction through the microRNA–218/roundabout 1 and microRNA–218/heme oxygenase–1 axes
2018 · External reference
10.3390/cells9061473
10.3390/cells9061473 · External reference
10.1038/s42255-019-0078-z
10.1038/s42255-019-0078-z · External reference
Knock-down of circular RNA H19 induces human adipose-derived stem cells adipogenic differentiation via a mechanism involving the polypyrimidine tract-binding protein 1
10.1016/j.yexcr.2019.111753 · 2020 · External reference
Circadian rhythms and proteomics: It's all about posttranslational modifications!
10.1002/wsbm.1450 · 2019 · External reference
10.2152/jmi.54.289
10.2152/jmi.54.289 · External reference
Proteomic identification of human serum biomarkers in diabetes mellitus type 2
10.1016/j.jpba.2009.11.016 · 2010 · External reference
Serum monomeric α2-macroglobulin as a clinical biomarker in diabetes
10.1016/j.atherosclerosis.2013.02.035 · 2013 · External reference
Protein Biomarkers for Insulin Resistance and Type 2 Diabetes Risk in Two Large Community Cohorts
10.2337/db15-0881 · 2016 · External reference
Protein markers and risk of type 2 diabetes and prediabetes: a targeted proteomics approach in the KORA F4/FF4 study
10.1007/s10654-018-0475-8 · 2019 · External reference
Proteomics approach to identify serum biomarkers associated with the progression of diabetes in Korean patients with abdominal obesity
10.1371/journal.pone.0222032 · 2019 · External reference
10.1016/j.mce.2014.11.021
10.1016/j.mce.2014.11.021 · External reference
10.5483/bmbrep.2012.45.12.235
10.5483/bmbrep.2012.45.12.235 · External reference
Investigation of adipocyte proteome during the differentiation of brown preadipocytes
10.1016/j.jprot.2013.10.005 · 2013 · External reference
Emerging Applications of Metabolomics to Assess the Efficacy of Traditional Chinese Medicines for Treating Type 2 Diabetes Mellitus
10.3389/fphar.2021.735410 · 2021 · External reference
10.3390/cells10112832
10.3390/cells10112832 · External reference
10.1016/j.cmet.2009.02.002
10.1016/j.cmet.2009.02.002 · External reference
10.2337/dc15-2251
10.2337/dc15-2251 · External reference
10.1111/1753-0407.12645
10.1111/1753-0407.12645 · External reference
10.3803/enm.2019.34.3.234
10.3803/enm.2019.34.3.234 · External reference
Genetic evidence of a causal effect of insulin resistance on branched-chain amino acid levels
10.1007/s00125-017-4222-6 · 2017 · External reference
Amino acid and insulin signaling via the mTOR/p70 S6 kinase pathway. A negative feedback mechanism leading to insulin resistance in skeletal muscle cells
10.1074/jbc.m106703200 · 2001 · External reference
10.1210/jc.2014-2357
10.1210/jc.2014-2357 · External reference
10.2337/dc17-1642
10.2337/dc17-1642 · External reference
2-Aminoadipic acid is a biomarker for diabetes risk
10.1172/jci64801 · 2013 · External reference
Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease
10.1056/nejmra1011035 · 2014 · External reference
Glycerol and fatty acids in serum predict the development of hyperglycemia and type 2 diabetes in Finnish men
10.2337/dc13-0800 · 2013 · External reference
Metabolic signatures and risk of type 2 diabetes in a Chinese population: an untargeted metabolomics study using both LC-MS and GC-MS
10.1007/s00125-016-4069-2 · 2016 · External reference
10.3390/jcm9020321
10.3390/jcm9020321 · External reference
Plasma Lipidomic Profiling and Risk of Type 2 Diabetes in the PREDIMED Trial
10.2337/dc18-0840 · 2018 · External reference
Untargeted metabolic profiling identifies altered serum metabolites of type 2 diabetes mellitus in a prospective, nested case control study
10.1373/clinchem.2014.228965 · 2015 · External reference
Exploring the Diversity of Sugar Compounds in Healthy, Prediabetic, and Diabetic Volunteers
10.1002/mnfr.201901190 · 2020 · External reference
Serum metabolic signatures of fulminant type 1 diabetes
10.1021/pr300523x · 2012 · External reference
1H NMR based serum metabolic profiling reveals differentiating biomarkers in patients with diabetes and diabetes-related complication
10.1016/j.dsx.2018.09.009 · 2019 · External reference
10.1016/j.arcmed.2017.11.003
10.1016/j.arcmed.2017.11.003 · External reference
10.1136/gutjnl-2020-323071
10.1136/gutjnl-2020-323071 · External reference
10.1038/s41574-019-0156-z
10.1038/s41574-019-0156-z · External reference
10.21037/tgh.2018.07.06
10.21037/tgh.2018.07.06 · External reference
10.1038/sj.emboj.7601049
10.1038/sj.emboj.7601049 · External reference
Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome
10.3389/fphar.2018.01382 · 2018 · External reference
Gut microbiota-derived metabolite trimethylamine N-oxide (TMAO) potentially increases the risk of obesity in adults: An exploratory systematic review and dose-response meta- analysis
10.1111/obr.12993 · 2020 · External reference
Association between microbiota-dependent metabolite trimethylamine-N-oxide and type 2 diabetes
10.3945/ajcn.117.157107 · 2017 · External reference
10.1111/obr.12843
10.1111/obr.12843 · External reference
10.1038/s41575-019-0258-z
10.1038/s41575-019-0258-z · External reference
10.1016/j.cmet.2018.07.001
10.1016/j.cmet.2018.07.001 · External reference
10.1016/j.cell.2018.09.055
10.1016/j.cell.2018.09.055 · External reference
1,5-Anhydroglucitol in diabetes mellitus
10.1007/s12020-012-9760-6 · 2013 · External reference
Non-targeted metabolomics combined with genetic analyses identifies bile acid synthesis and phospholipid metabolism as being associated with incident type 2 diabetes
10.1007/s00125-016-4041-1 · 2016 · External reference
Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significance
10.2337/db12-0707 · 2013 · External reference
10.1371/journal.pone.0010883
10.1371/journal.pone.0010883 · External reference
Reduction of alpha-ketobutyrate by human serum
10.1038/1881110a0 · 1960 · External reference
Recent Progress in Metabolic Syndrome Research and Therapeutics
10.3390/ijms22136862 · 2021 · External reference
Metabolomic and lipidomic assessment of the metabolic syndrome in Dutch middle-aged individuals reveals novel biological signatures separating health and disease
10.1007/s11306-019-1484-7 · 2019 · External reference
Gut Microbiota, Host Organism, and Diet Trialogue in Diabetes and Obesity
10.3389/fnut.2019.00021 · 2019 · External reference
10.3748/wjg.v21.i29.8787
10.3748/wjg.v21.i29.8787 · External reference
10.1017/s0007114516001045
10.1017/s0007114516001045 · External reference
Characteristics of gut microbiota and its response to a Chinese Herbal Formula in elder patients with metabolic syndrome
10.5582/ddt.2018.01036 · 2018 · External reference
Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters
10.1038/tpj.2012.43 · 2013 · External reference
10.1038/nature12198
10.1038/nature12198 · External reference
10.1016/j.diabet.2016.04.004
10.1016/j.diabet.2016.04.004 · External reference
Comparison of the gut microbiota composition between obese and non-obese individuals in a Japanese population, as analyzed by terminal restriction fragment length polymorphism and next-generation sequencing
10.1186/s12876-015-0330-2 · 2015 · External reference
10.1136/gutjnl-2014-308778
10.1136/gutjnl-2014-308778 · External reference
10.1038/nature15766
10.1038/nature15766 · External reference
10.1038/nature05414
10.1038/nature05414 · External reference
10.1038/nm.4358
10.1038/nm.4358 · External reference
10.1016/j.chom.2019.07.004
10.1016/j.chom.2019.07.004 · External reference
Diabetes causes marked inhibition of mitochondrial metabolism in pancreatic β-cells
10.1038/s41467-019-10189-x · 2019 · External reference
Integrative genomics reveal a role for MCPIP1 in adipogenesis and adipocyte metabolism
10.1007/s00018-019-03434-5 · 2020 · External reference
10.1038/s41586-020-2928-y
10.1038/s41586-020-2928-y · External reference
Small intestine proteomics coupled with serum metabolomics reveal disruption of amino acid metabolism in Chinese hamsters with type 2 diabetes mellitus
10.1016/j.jprot.2020.103823 · 2020 · External reference
10.1038/nature18646
10.1038/nature18646 · External reference
Decreased Abundance of Akkermansia muciniphila Leads to the Impairment of Insulin Secretion and Glucose Homeostasis in Lean Type 2 Diabetes
10.1002/advs.202100536 · 2021 · External reference
10.1038/s41586-019-1236-x
10.1038/s41586-019-1236-x · External reference
10.1038/s41591-019-0414-6
10.1038/s41591-019-0414-6 · External reference
10.1038/nrd.2016.32
10.1038/nrd.2016.32 · External reference
Brain-gut-microbe communication in health and disease
10.3389/fphys.2011.00094 · 2011 · External reference
10.1111/jdi.12673
10.1111/jdi.12673 · External reference
Probiotic yogurt improves antioxidant status in type 2 diabetic patients
10.1016/j.nut.2011.08.013 · 2012 · External reference
